Abstract
The purpose of the research was the study of the prebiotic and hypolipidemic effects of 12-week treatment by psillium of patients with uncomplicated diverticular disease and hyperlipidemia. It has been established that the examined medicine has not any by-effects, normalizes intestinal motility and lowers a pain syndrome and flatulence. Prebiotic effect has proved by higher concentration of short-chain fatty acids in faeces and reduction of anaerobic index. Psillium certainly reduces levels of hyperlipidemia and could be recommended as hypolipidemic remedy for monotherapy as long as base datum of cholesterol is less than 6,4 mmol/l.
Publication types
-
Clinical Trial
-
English Abstract
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Cathartics / administration & dosage
-
Cathartics / therapeutic use*
-
Diverticulosis, Colonic / blood
-
Diverticulosis, Colonic / complications
-
Diverticulosis, Colonic / drug therapy*
-
Fatty Acids, Volatile / analysis
-
Feces / chemistry
-
Female
-
Gastrointestinal Motility / drug effects
-
Humans
-
Hyperlipidemias / blood
-
Hyperlipidemias / complications
-
Hyperlipidemias / drug therapy*
-
Hypolipidemic Agents / administration & dosage
-
Hypolipidemic Agents / therapeutic use*
-
Lipids / blood
-
Male
-
Middle Aged
-
Psyllium / administration & dosage
-
Psyllium / therapeutic use*
-
Treatment Outcome
Substances
-
Cathartics
-
Fatty Acids, Volatile
-
Hypolipidemic Agents
-
Lipids
-
Psyllium